Immunotherapy and Novel Combinations

Cancer treatments are reworked with recent advances in cancer therapy. As monotherapies, these agents have incontestible clinical activity across several tumour sorts. Further advances within the effectiveness of cancer immunotherapies would require targeting growth reaction at multiple levels, which can be accomplished through combination approaches. This review discusses this landscape of cancer therapy, mixtures in clinical development, methods for dose choice and trial style, and clinical materia medica and restrictive issue.

  • Oncolytic Virus Immunotherapy
  • Monoclonal antibodies and tumor-agnostic therapies
  • Vaccines Targeting Shared Antigens
  • Vaccines Targeting Neoantigens
  • Immune Checkpoint Inhibitors therapy
  • Targeted therapy and checkpoint immunotherapy combinations

Related Conference of Immunotherapy and Novel Combinations

Immunotherapy and Novel Combinations Conference Speakers